Recent Headlines
Within Biotechnology
MD Stem Cells Begins Intravitreal Stem Cell Treatments for Severe Visual Loss
New Intravitreal Stem Cell Injection Approach to Improve Vision is Now Available through MD Stem Cells. - February 15, 2013 - MD Stem Cells
Greenwerkz Releases R4 Ultra-High CBD, Non-Psychoactive Strain as "Open Source"
Greenwerkz' high CBD/low THC strain genetics to become available to patients and medical marijuana centers (MMCs) in Colorado, free of charge. - February 14, 2013 - Greenwerkz
IonSense to Present Direct Analysis in Real Time (DART®) Analysis for Rapid Drug Screening at the American Academy of Forensic Sciences (AAFS) 65th Annual Meeting
IonSense will present its DART-MS technology for rapid screening of urine samples using solid phase microfiber probes, enabling sample inspection for drugs of abuse in minutes. This is the first time IonSense will exhibit at the AAFS meeting, February 18-23, 2013 in Washington, D.C., Booth 405. - February 14, 2013 - IonSense, Inc.
Local Cardiac Rehab Center Will Provide a Free Service to Help Raise Heart Awareness for American Heart Month
Health Enhancement Cardiac Rehab Centers Announces its Participation in National EECP® Therapy Week. - February 14, 2013 - International EECP Therapist Association
Raising Heart Awareness in February has Special Significance for Local Hospital
Advocate Christ Medical Center Announces its Participation in National EECP® Therapy Week. - February 14, 2013 - International EECP Therapist Association
Local Cardiology practice Raises Heart Awareness for American Heart Month
Heart Centers of America Announces its Participation in National EECP® Therapy Week. - February 13, 2013 - International EECP Therapist Association
SFL’s Managing Director Invited to Speak at MEDTEC Europe Event in Stuttgart, Germany
SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation on the classification and regulation of drug/device combinations at the MEDTEC Europe event to be held in Stuttgart, Germany from 26 to 28 February 2013. - February 13, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
National Simultaneous Red Balloon Release Raises Heart Awareness for American Heart Month
Ohio Heart and Vascular Center Announces Its Participation in National EECP® Therapy Week - February 10, 2013 - International EECP Therapist Association
Creagri, Inc. Announces a Strategic Distribution Agreement for Olivenol® Plus Line of Dietary Supplements and Skincare Products
Creagri, Inc., and NewWave Biosciences, Inc., announced today that they have reached an agreement for the distribution of Olivenol® plus products across the therapeutic channel. - February 09, 2013 - Creagri, Inc.
AnaSpec Introduces Two New SensoLyte® Cathepsin L Assay Kits
AnaSpec is pleased to announce the release of two new SensoLyte® assay kits for the measurement of Cathepsin L activity – the SensoLyte® 520 and Rh110 Cathepsin L Assay Kits. The former utilizes a FRET (fluorescent resonance energy transfer)-based peptide substrate and the latter, a... - February 09, 2013 - AnaSpec, EGT Group
MoBiTec GmbH, Germany, is Offering Glycan Arrays for Multiple Analysis of Glycan-Related Interactions
MoBiTec Germany, in cooperation with the Japanese company Sumitomo Bakelite Co. Ltd., is offering to its European customers Glycan Arrays that are useful for studies on the interaction of microorganisms, analysis of glycan-binding proteins, autoantibodies and more. - February 09, 2013 - MoBiTec GmbH
ImmunoReagents Enters Distributorship Agreement with Abyntek Biopharma; Key Spanish Supplier of Antibodies
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced Abyntek Biopharma as its new distributor in Spain. ImmunoReagents and Abyntek will partner to distribute top quality antibodies and... - February 08, 2013 - ImmunoReagents Inc.
BANG® – as Official Energy Drink of NHL Florida Panthers & BB&T Center
It was just announced that VPX’s BANG® will be named official energy drink of the NHL Florida Panthers and the BB&T Center, formerly known as the Bank Atlantic Center. - February 07, 2013 - VIRUN
Billion Cell Milestone Reached in Stem Cell Treatment
MD Stem Cells Reports Almost Two Billion Cells Used in Eye Stem Cell Treatment in Florida. - February 07, 2013 - MD Stem Cells
Bioo Scientific Releases NEXTflex™ 16S V4 Amplicon-Seq Kit for Bacterial Metagenomics Studies
The NEXTflex™ 16S V4 Amplicon-Seq Kit has been developed to simplify bacterial metagenomics studies using Illumina® HiSeq and MiSeq platforms. This kit allows users to go from sample to sequence in two hours, making it the fastest library prep kit available. Using specialized NEXTflex... - February 06, 2013 - Bioo Scientific
Molecular Medicine Tri-Conference 2013 - Complimentary Hall Passes Now Available
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference (Triconference.com/hallpass) - February 02, 2013 - Cambridge Healthtech Institute
MOgene Announces Partnership with Intuitive Genomics to Expand Bioinformatics Capabilities
MOgene LC, a full service genomics service provider based in Saint Louis, MO announces a partnership with Intuitive Genomics, Inc. to further expand its bioinformatics capabilities. This decision follows several years of successfully working with Intuitive Genomics to deliver some very promising... - January 28, 2013 - MOgene, LC
Colorado BioScience Association Focuses on 2013's Key State and Federal Legislative Initiatives at Fifth Annual "BioScience Day at the Capitol"
Colorado BioScience Association (CBSA) is hosting its fifth annual "BioScience Day at the Capitol" on January 30. The event will feature Mark Leahey, President and CEO, Medical Device Manufacturers Association (MDMA) presenting the "State of the Medical Device Industry" and efforts MDMA is leading in Washington to repeal the Medical Device Tax. - January 28, 2013 - Colorado BioScience Association
CHI Releases List of Delegates for Targeting Cancer Stem Cells Symposium in San Francisco, CA
To be held on February 11-12, 2013 at the Moscone North Convention Center, San Francisco, CA - Part of the Molecular Med TRI-CON 2013. - January 26, 2013 - Cambridge Healthtech Institute
Tampa Bay Surgeons Offer Virtually Scarless Weight-Loss Procedure
Sun Coast Bariatrics is using the SPIDER® Surgical System to perform single-incision sleeve gastrectomy. - January 26, 2013 - TransEnterix
IonSense Awarded Massachusetts Workforce Training Grant. Adds New Sales Management.
IonSense, Inc. announced that they are a recipient of one of the 87 Workforce Training Grants awarded by the state of Massachusetts. This grant will enable the company to provide training to a number of employees in the areas of software development and engineering. “We are growing our... - January 25, 2013 - IonSense, Inc.
Optic Nerve Vision Loss Reversed with New Stem Cell Treatment
MD Stem Cells helps nearly blind car accident victim regain her sight in Florida and see her mother’s face again- other neurologic benefits reported as well. - January 24, 2013 - MD Stem Cells
Stevens Undergraduates Present Research on Reducing Back Pain
Lower back pain is the second most common cause of disability for adults in the United States. Faced with the rising number of individuals suffering from the condition, undergraduate students Emily Noonan and Hanna Sidoti at the Stevens Institute of Technology will be presenting their research on... - January 24, 2013 - Stevens Institute of Technology
Novel Health Strategies Announces Publication of Annual and Recurring Strategy Overview on Emerging Life Sciences Market Trends
Novel Health Strategies Study Shows Oncology, Diabetes and Auto-Immune Indications Driving Growth of the Biotech Sector; More Products Facing Market Access Challenges. - January 24, 2013 - Novel Health Strategies
Stevens Students Enter National Academy of Engineering Ethics Video Contest
Team of engineers proposes reassessment of nuclear energy as a sustainable power source as part of the National Academy of Engineering (NAE) Online Ethics Center (OEC) Energy Ethics Video Challenge. - January 16, 2013 - Stevens Institute of Technology
MD Stem Cells Improves Myopic Macular Degeneration with New Stem Cell Treatment
MD Stem Cells helps Australian patient travel half way around the world for stem cell treatment in Florida to achieve significant improvement in vision. - January 14, 2013 - MD Stem Cells
AnaSpec Offers a Wide Selection of SYBR® qPCR MasterMixes and Core Kits
AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. - January 12, 2013 - AnaSpec, EGT Group
Bioo Scientific Launches AflaPure™ Immunoaffinity Columns for Aflatoxin Detection in Food
Bioo Scientific developed two new immunoaffinity columns, AflaPure™ Total and AflaPure™ M1, for the convenient detection of aflatoxin in a variety of food and dairy samples in less than 30 minutes. - January 12, 2013 - Bioo Scientific
The Colorado BioScience Association Launches Its Colorado BioScience Institute to Support Much Needed Educational & Workforce Programs for the State's Bioscience Industry
Colorado BioScience Association (CBSA) is officially launching the Colorado BioScience Institute (The Institute) today. The CBSA leadership team has set a kick-off goal of $100,000 for The Institute this year. The initial $20,000 raised, including a generous matching gift from PhRMA of up to $5,000, will support the Colorado launch of one of its flagship programs, the BioGENEius Challenge. - January 07, 2013 - Colorado BioScience Association
ImmunoReagents Signs French Distributorship Agreement with Ozyme
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Ozyme as its new distributor in France. ImmunoReagents and Ozyme will partner to distribute top quality antibodies and... - January 04, 2013 - ImmunoReagents Inc.
MoBiTec GmbH, Germany, is Offering TurboLigation™ Kit, Enabling Quick Ligation of DNA Molecules in Just 5 Minutes at a Bargain Price
Combining heterologous DNA molecules is a key process in most traditional molecular cloning experiments. This process, facilitated by the enzyme DNA ligase, usually takes about 16 hours. With the TurboLigation™ Kit the reaction time is greatly reduced down to just 5 minutes without compromising the efficiency. - December 22, 2012 - MoBiTec GmbH
ImmunoReagents Signs Swiss Distributorship Agreement with LabForce Ag
ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of LabForce as its new distributor in Switzerland. ImmunoReagents and LabForce will partner to distribute top quality... - December 20, 2012 - ImmunoReagents Inc.
CreAgri, Inc. Receives 2012 Best of Hayward Award
The Hayward Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Hayward area. - December 20, 2012 - Creagri, Inc.
Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector
Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd
2012 - An Award-Winning Year for SFL
This year, SFL’s multifunctional expertise has been independently recognised through two important business awards. In July, Shayesteh Fürst-Ladani, Managing Director of the company, received the Open University Business School’s Alumni Award Outstanding Contribution to an... - December 19, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
General Biologicals Corporation Signs ALPCO as a Distributor in North America
ALPCO will distribute Infectious Disease assays from GBC in North America. - December 18, 2012 - ALPCO
Stevens Wins NSF Grant for International, Multidisciplinary Partnership to Study the Amazon River
Dr. Michael Bruno leads cross-disciplinary effort to observe and model a globally critical coastal maritime system. - December 15, 2012 - Stevens Institute of Technology
MoBiTec GmbH, Germany, Introduces New Multiplex Secretion Gene Expression System for Bacillus subtilis
Bacillus subtilis has become an increasingly popular host for recombinant protein expression. With its ability to secrete protein directly into culture media, and designation by the U.S. Food and Drug Administration as an organism that is Generally Regarded As Safe (GRAS), the majority of industrially-produced enzymes are expressed in Bacillus species such as B. subtilis. To address this, MoBiTec introduces the new Bacillus subtilis Multiplex Secretion Expression System. - December 13, 2012 - MoBiTec GmbH
ALPCO Diagnostics Recognized in Support of American Red Cross’ Hurricane Sandy Relief Efforts
ALPCO presented with plaque of recognition for their contribution to the American Red Cross' Hurricane Sandy Relief Fund. - December 12, 2012 - ALPCO
ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agreement at MEDICA 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012 - ALPCO
Bringing Effective Optimization to Designers and Design Engineers
Design Simulation Technologies, Inc. (DST) announced today that they have chosen to embed the revolutionary SHERPA optimization engine, from Red Cedar Technology, into their SimWise 4D simulation software. SimWise 4D integrates motion simulation and structural simulation allowing design engineers... - December 08, 2012 - Red Cedar Technology
ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreement
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012 - ALPCO
Colorado BioScience Association Awards the Industry’s Best of 2012
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its Annual Awards Dinner at the Hyatt Convention Center, Denver. The celebration showcases the significant achievements from the bioscience industry throughout the past year. - December 07, 2012 - Colorado BioScience Association
Highly Sensitive SensoLyte® HDACs and HATs Assay Kits for Epigenetics Research
AnaSpec has developed a series of highly sensitive assay kits for the detection of the activities of HDAC (Histone Deacetylase), SIRT (Sirtuin) 1 & 2 or HAT (Histone Acetyltransferases). - December 07, 2012 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® ThT Aβ42 & Aβ40 Aggregation Kits
AnaSpec has developed the SensoLyte® ThT Aß40 and Aß42 Aggregation kits to provide a convenient and standard method for measurement of Aß40 and Aß42 aggregation, respectively. - December 06, 2012 - AnaSpec, EGT Group
Creating Sustainable Energy from Microalgae
Funded by the U.S. Department of Energy Office of Biomass Program, Dr. Adeniyi Lawal of Stevens Institute of Technology will be leading a team investigating microalgae as a biomass fuel source. The research team is developing a transformative technology that converts the renewable and abundant supply of algae into cost-competitive, high-performance biofuels. - December 06, 2012 - Stevens Institute of Technology
Local OB-GYN Practice Helps Study Potential New Treatment for HPV and Cervical Cancer
Clinical research study at Richmond-based women’s health practice, Virginia Women’s Center, examines the potential of a new vaccine to treat women who have been diagnosed with HPV and to prevent the further development of cervical cancer. - December 06, 2012 - Virginia Women's Center
VPX Sports® Introduces BANG® – an Intelligent Beverage Design Aimed to Change Typical “Energy Drink” Perception
The beverage innovators at VPX® have re-defined the “energy drink” category by introducing BANG® -- a novel, great-tasting 16 ounce carbonated beverage formulated to fuel the brain and body. “BANG® is not your typical high sugar, health robbing beverage,” rather, BANG® consists of several patent-pending compounds and patented compositions intelligently designed to deliver results “…without the sugar-induced metabolic mayhem and crash.” -Jack Owoc, Chief Executive & Science Officer for VPX Sports - November 30, 2012 - VIRUN
Dr. Larry Miller Selected for SPINE Journal Advisory Board
Dr. Larry Miller, a Senior Associate at the The Jon Block Group, has accepted an invitation by SPINE Journal to join their Advisory Board. SPINE is an international, peer-reviewed, bi-weekly periodical and an important authority in the academic spine field. It is the premier subspecialty journal... - November 29, 2012 - Jon Block Group
Colorado BioScience Association Announces Finalists for "Company of the Year" at Its Annual Awards Celebration, December 6th
The Colorado BioScience Association (CBSA) has announced finalists for "Company of the Year" (COY) at its 2012 Awards Dinner Celebration -- Thursday, December 6, at the Hyatt Convention Center, 650 15th Street, Denver. CBSA's COY finalists include: BaI Seal, Colorado Springs; Covidien (Colorado operations), Boulder; and TOLMAR Inc., Fort Collins. - November 26, 2012 - Colorado BioScience Association